Yongli Xuan

478 total citations
21 papers, 386 citations indexed

About

Yongli Xuan is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yongli Xuan has authored 21 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yongli Xuan's work include Signaling Pathways in Disease (4 papers), Cardiac Fibrosis and Remodeling (4 papers) and Acute Kidney Injury Research (4 papers). Yongli Xuan is often cited by papers focused on Signaling Pathways in Disease (4 papers), Cardiac Fibrosis and Remodeling (4 papers) and Acute Kidney Injury Research (4 papers). Yongli Xuan collaborates with scholars based in China and Australia. Yongli Xuan's co-authors include Wenjuan Cheng, Hesheng Hu, Xiaolu Li, Jie Yin, Na Yang, Suhua Yan, Mei Xue, Suhua Yan, Yugen Shi and Mei Xue and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Gene.

In The Last Decade

Yongli Xuan

21 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongli Xuan China 12 179 134 67 62 43 21 386
Suhua Yan China 13 138 0.8× 204 1.5× 65 1.0× 52 0.8× 34 0.8× 32 411
Alexander Reinecke Germany 12 322 1.8× 214 1.6× 68 1.0× 52 0.8× 38 0.9× 30 561
Tanneale Marshall Australia 8 339 1.9× 177 1.3× 51 0.8× 34 0.5× 25 0.6× 8 503
Hui-Feng Cheng China 7 125 0.7× 171 1.3× 35 0.5× 31 0.5× 18 0.4× 8 366
Darla L. Tharp United States 12 244 1.4× 319 2.4× 63 0.9× 55 0.9× 53 1.2× 27 630
Toshiko Kanbe Japan 10 193 1.1× 162 1.2× 101 1.5× 88 1.4× 42 1.0× 12 483
Takahiko Kiyooka Japan 13 271 1.5× 200 1.5× 115 1.7× 20 0.3× 26 0.6× 30 637
Magdalena A. Zabielska-Kaczorowska Poland 13 76 0.4× 160 1.2× 72 1.1× 31 0.5× 35 0.8× 27 409
Alexander Widiapradja Australia 12 105 0.6× 186 1.4× 50 0.7× 69 1.1× 176 4.1× 17 569
Shota Tanaka Japan 12 56 0.3× 118 0.9× 52 0.8× 21 0.3× 39 0.9× 50 408

Countries citing papers authored by Yongli Xuan

Since Specialization
Citations

This map shows the geographic impact of Yongli Xuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongli Xuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongli Xuan more than expected).

Fields of papers citing papers by Yongli Xuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongli Xuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongli Xuan. The network helps show where Yongli Xuan may publish in the future.

Co-authorship network of co-authors of Yongli Xuan

This figure shows the co-authorship network connecting the top 25 collaborators of Yongli Xuan. A scholar is included among the top collaborators of Yongli Xuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongli Xuan. Yongli Xuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ma, Kai, Jing Li, Di Zheng, et al.. (2022). Development and Validation of a Risk Nomogram Model for Predicting Contrast-Induced Acute Kidney Injury in Patients with Non-ST-Elevation Acute Coronary Syndrome Undergoing Primary Percutaneous Coronary Intervention. SHILAP Revista de lepidopterología. 11 indexed citations
5.
Song, Liang, Shun Yao, Di Zheng, Yongli Xuan, & Wenhua Li. (2021). Astaxanthin attenuates contrast-induced acute kidney injury in rats via ROS/NLRP3 inflammasome. International Urology and Nephrology. 54(6). 1355–1364. 17 indexed citations
7.
Zhang, Fengyun, Yongli Xuan, Jinjin Cui, et al.. (2017). Nicorandil modulated macrophages activation and polarization via NF-κb signaling pathway. Molecular Immunology. 88. 69–78. 32 indexed citations
8.
Yang, Na, Wenjuan Cheng, Hesheng Hu, et al.. (2016). Atorvastatin attenuates sympathetic hyperinnervation together with the augmentation of M2 macrophages in rats postmyocardial infarction. Cardiovascular Therapeutics. 34(4). 234–244. 33 indexed citations
9.
Xuan, Yongli, Rong He, Bin Han, Tinghua Wu, & Ying Wu. (2016). Catalytic Conversion of Cellulose into 5-Hydroxymethylfurfural Using [PSMIM]HSO4 and ZnSO4·7H2O Co-catalyst in Biphasic System. Waste and Biomass Valorization. 9(3). 401–408. 11 indexed citations
10.
Hu, Hesheng, Yongli Xuan, Mei Xue, et al.. (2016). Semaphorin 3A attenuates cardiac autonomic disorders and reduces inducible ventricular arrhythmias in rats with experimental myocardial infarction. BMC Cardiovascular Disorders. 16(1). 16–16. 33 indexed citations
11.
Xuan, Yongli, Ye Wang, Mei Xue, et al.. (2015). In rats the duration of diabetes influences its impact on cardiac autonomic innervations and electrophysiology. Autonomic Neuroscience. 189. 31–36. 15 indexed citations
12.
Li, Xinran, Hesheng Hu, Ye Wang, et al.. (2015). Valsartan Upregulates Kir2.1 in Rats Suffering from Myocardial Infarction via Casein Kinase 2. Cardiovascular Drugs and Therapy. 29(3). 209–218. 11 indexed citations
13.
Hu, Hesheng, Ye Wang, Mei Xue, et al.. (2015). Valsartan Attenuates KIR2.1 by Downregulating the Th1 Immune Response in Rats Following Myocardial Infarction. Journal of Cardiovascular Pharmacology. 67(3). 252–259. 7 indexed citations
14.
Li, Xinran, Hesheng Hu, Ye Wang, et al.. (2015). Valsartan ameliorates KIR2.1 in rats with myocardial infarction via the NF-κB-miR-16 pathway. Gene. 590(2). 201–209. 9 indexed citations
15.
Hu, Hesheng, Yongli Xuan, Ye Wang, et al.. (2014). Targeted NGF siRNA Delivery Attenuates Sympathetic Nerve Sprouting and Deteriorates Cardiac Dysfunction in Rats with Myocardial Infarction. PLoS ONE. 9(4). e95106–e95106. 38 indexed citations
16.
Wang, Ye, Ju Liu, Hesheng Hu, et al.. (2013). Myocardial infarction induces sympathetic hyperinnervation via a nuclear factor-κB-dependent pathway in rabbit hearts. Neuroscience Letters. 535. 128–133. 21 indexed citations
17.
Wang, Ye, Mei Xue, Yongli Xuan, et al.. (2013). Mesenchymal Stem Cell Therapy Improves Diabetic Cardiac Autonomic Neuropathy and Decreases the Inducibility of Ventricular Arrhythmias. Heart Lung and Circulation. 22(12). 1018–1025. 17 indexed citations
18.
Xue, Mei, Yongli Xuan, Ye Wang, et al.. (2013). Exogenous Nerve Growth Factor Promotes the Repair of Cardiac Sympathetic Heterogeneity and Electrophysiological Instability in Diabetic Rats. Cardiology. 127(3). 155–163. 3 indexed citations
19.
Wang, Ye, Ju Liu, Hesheng Hu, et al.. (2013). Metoprolol-Mediated Amelioration of Sympathetic Nerve Sprouting after Myocardial Infarction. Cardiology. 126(1). 50–58. 12 indexed citations
20.
Wang, Ye, Yongli Xuan, Hesheng Hu, et al.. (2012). Risk of Ventricular Arrhythmias after Myocardial Infarction with Diabetes Associated with Sympathetic Neural Remodeling in Rabbits. Cardiology. 121(1). 1–9. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026